Search for: "MYLAN TECHNOLOGIES INC."
Results 61 - 80
of 149
Sort by Relevance
|
Sort by Date
4 Dec 2013, 4:03 am
FAS Technologies, Inc., 138 F.3d 1448 (Fed. [read post]
22 Oct 2013, 2:28 pm
Inc., et al., C.A. [read post]
17 Oct 2013, 5:00 am
Medtronic, Inc., 238 F. [read post]
13 Mar 2013, 4:05 pm
Mylan Technologies Inc., et al., C.A. [read post]
1 Mar 2013, 6:28 am
Related posts:Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
3 Jun 2012, 12:17 pm
Mylan Labs., Inc., 520 F.3d 1358, 1365 (Fed. [read post]
31 May 2012, 7:50 am
Mylan Pharmaceuticals, Inc., Mylan, Inc. [read post]
1 Mar 2012, 9:00 pm
Mylan Pharm., Inc., C.A. [read post]
1 Mar 2012, 9:00 pm
Mylan Pharm., Inc., C.A. [read post]
12 Jan 2012, 9:38 am
Mylan Inc., No. 2:09cv1692, 2009 U.S. [read post]
10 Jan 2012, 11:58 pm
Mylan Inc., No. 2:09cv1692, 2009 U.S. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc,… [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
15 Jun 2011, 4:56 am
Mylan Inc. et al. [read post]
26 May 2011, 10:54 am
Mylan, Inc., 718 F. [read post]
4 May 2011, 7:52 am
Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms Fentanyl Fentanyl Extended Release Transdermal System Watson … [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
1 Mar 2011, 8:38 pm
Roche Molecular Systems, Inc. [read post]
